XNASIMCC
Market cap6mUSD
Dec 23, Last price
2.20USD
1D
5.74%
1Q
-4.37%
Name
IM Cannabis Corp
Chart & Performance
Profile
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑04 | 2018‑04 | 2017‑04 | 2016‑04 | 2015‑04 | |
Income | ||||||||||
Revenues | 48,804 -10.18% | 54,335 0.06% | 54,300 241.72% | |||||||
Cost of revenue | 57,990 | 80,742 | 92,689 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (9,186) | (26,407) | (38,389) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 771 | (1,138) | 505 | |||||||
Tax Rate | ||||||||||
NOPAT | (9,957) | (25,269) | (38,894) | |||||||
Net income | (9,498) -61.89% | (24,921) 34.58% | (18,518) -35.55% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 1,688 | 3,756 | 28,131 | |||||||
BB yield | -221.31% | -53.66% | -145.31% | |||||||
Debt | ||||||||||
Debt current | 12,573 | 10,060 | 11,056 | |||||||
Long-term debt | 2,478 | 3,363 | 37,586 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 133 | 254 | 6,413 | |||||||
Net debt | 10,953 | 8,564 | 29,181 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (8,075) | (12,640) | (34,372) | |||||||
CAPEX | (581) | (1,562) | (4,595) | |||||||
Cash from investing activities | (1,182) | (1,408) | (9,012) | |||||||
Cash from financing activities | 9,417 | 4,762 | 48,731 | |||||||
FCF | (4,925) | 36,655 | (95,809) | |||||||
Balance | ||||||||||
Cash | 1,813 | 2,449 | 17,032 | |||||||
Long term investments | 2,285 | 2,410 | 2,429 | |||||||
Excess cash | 1,658 | 2,142 | 16,746 | |||||||
Stockholders' equity | 4,063 | 9,290 | 193,257 | |||||||
Invested Capital | 25,957 | 33,443 | 223,880 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 2,136 | 7,181 | 580 | |||||||
Price | 0.36 -63.38% | 0.97 -97.08% | 33.40 71.28% | |||||||
Market cap | 763 -89.10% | 7,000 -63.84% | 19,359 -74.26% | |||||||
EV | 10,947 | 16,709 | 52,249 | |||||||
EBITDA | (6,190) | (19,076) | (32,660) | |||||||
EV/EBITDA | ||||||||||
Interest | 3,671 | 1,972 | 1,648 | |||||||
Interest/NOPBT |